The global burden of skin cancer is expected to grow as the population aged 65 years and older increases in the next 25 years.

Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant ...

Additional data presented at ASCO highlights Libtayo’s ability to hold off recurrence of a type of skin cancer.

Skin cancer is often under-recognised in India, especially around the eyes. Here are some key facts everyone should know ...